Company registration number 16089251 (England and Wales)
KONG BLOODSTOCK LTD
UNAUDITED FINANCIAL STATEMENTS
FOR THE PERIOD ENDED 30 NOVEMBER 2025
PAGES FOR FILING WITH REGISTRAR
KONG BLOODSTOCK LTD
CONTENTS
Page
Balance sheet
1
Notes to the financial statements
2 - 3
KONG BLOODSTOCK LTD
BALANCE SHEET
AS AT
30 NOVEMBER 2025
30 November 2025
- 1 -
2025
Notes
£
£
Current assets
Stocks
83,492
Debtors
9,578
Cash at bank and in hand
215
93,285
Creditors: amounts falling due within one year
3
(391,485)
Net current liabilities
(298,200)
Capital and reserves
Called up share capital
1
Profit and loss reserves
(298,201)
Total equity
(298,200)

For the financial period ended 30 November 2025 the company was entitled to exemption from audit under section 477 of the Companies Act 2006 relating to small companies.

T he members have not required the company to obtain an audit of its financial statements for the period in question in accordance with section 476.

The director acknowledges his responsibilities for complying with the requirements of the Companies Act 2006 with respect to accounting records and the preparation of financial statements.

These financial statements have been prepared and delivered in accordance with the provisions applicable to companies subject to the small companies regime.

The director of the company has elected not to include a copy of the profit and loss account within the financial statements.true

The financial statements were approved and signed by the director and authorised for issue on 14 August 2026
Mr S A Harvey
Director
Company registration number 16089251 (England and Wales)
KONG BLOODSTOCK LTD
NOTES TO THE FINANCIAL STATEMENTS
FOR THE PERIOD ENDED 30 NOVEMBER 2025
- 2 -
1
Accounting policies
Company information

Kong Bloodstock Ltd is a private company limited by shares incorporated in England and Wales. The registered office is 584 Wellsway, Bath, Somerset, BA2 2UE.

1.1
Basis of preparation

These financial statements have been prepared in accordance with FRS 102 “The Financial Reporting Standard applicable in the UK and Republic of Ireland” (“FRS 102”) and the requirements of the Companies Act 2006 as applicable to companies subject to the small companies regime. The disclosure requirements of section 1A of FRS 102 have been applied other than where additional disclosure is required to show a true and fair view.

The financial statements are prepared in sterling, which is the functional currency of the company. Monetary a mounts in these financial statements are rounded to the nearest £.

The financial statements have been prepared under the historical cost convention. The principal accounting policies adopted are set out below.

1.2
Going concern

A true t the time of approving the financial statements, t he director has a reasonable expectation that the company has adequate resources to continue in operational existence for the foreseeable future. Thus t he director continues to adopt the going concern basis of accounting in preparing the financial statements.

1.3
Revenue

Revenue comprises sales of goods or services provided to customers net of value added tax and other sales taxes, less an appropriate deduction for actual and expected returns and discounts. Revenue is recognised when performance obligations are satisfied and the control of goods or services is transferred to the buyer. Where the performance obligation is satisfied over time, revenue is recognised in accordance with its progress towards complete satisfaction of that performance obligation.

When cash inflows are deferred and represent a financing arrangement, the promised consideration is adjusted for the effects of the time value of money, which is recognised as interest income.

1.4
Stocks

Stocks are stated at the lower of cost and estimated selling price less costs to complete and sell. Cost comprises direct materials and, where applicable, direct labour costs and those overheads that have been incurred in bringing the stocks to their present location and condition.

Stocks held for distribution at no or nominal consideration are measured at the lower of cost and replacement cost, adjusted where applicable for any loss of service potential.

At each reporting date, an assessment is made for impairment. Any excess of the carrying amount of stocks over its estimated selling price less costs to complete and sell is recognised as an impairment loss in profit or loss. Reversals of impairment losses are also recognised in profit or loss.

1.5
Cash and cash equivalents

Cash and cash equivalents are basic financial assets and include cash in hand, deposits held at call with banks, other short-term liquid investments with original maturities of three months or less, and bank overdrafts. Bank overdrafts are shown within borrowings in current liabilities.

KONG BLOODSTOCK LTD
NOTES TO THE FINANCIAL STATEMENTS (CONTINUED)
FOR THE PERIOD ENDED 30 NOVEMBER 2025
1
Accounting policies
(Continued)
- 3 -
1.6
Employee benefits

The costs of short-term employee benefits are recognised as a liability and an expense, unless those costs are required to be recognised as part of the cost of stock or fixed assets.

The cost of any unused holiday entitlement is recognised in the period in which the employee’s services are received.

Termination benefits are recognised immediately as an expense when the company is demonstrably committed to terminate the employment of an employee or to provide termination benefits.

2
Employees

The average monthly number of persons (including directors) employed by the company during the period was:

2025
Number
Total
0
3
Creditors: amounts falling due within one year
2025
£
Trade creditors
11,562
Other creditors
379,923
391,485
2025-11-30 2024-11-19 false false false CCH Software CCH Accounts Production 2026.100 No description of principal activity Mr S Harvey 16089251 2024-11-19 2025-11-30 16089251 2025-11-30 16089251 core:CurrentFinancialInstruments core:WithinOneYear 2025-11-30 16089251 core:CurrentFinancialInstruments 2025-11-30 16089251 core:ShareCapital 2025-11-30 16089251 core:RetainedEarningsAccumulatedLosses 2025-11-30 16089251 bus:Director1 2024-11-19 2025-11-30 16089251 bus:PrivateLimitedCompanyLtd 2024-11-19 2025-11-30 16089251 bus:SmallCompaniesRegimeForAccounts 2024-11-19 2025-11-30 16089251 bus:FRS102 2024-11-19 2025-11-30 16089251 bus:AuditExempt-NoAccountantsReport 2024-11-19 2025-11-30 16089251 bus:FullAccounts 2024-11-19 2025-11-30 xbrli:pure xbrli:shares iso4217:GBP